T
Thomas V. O'Halloran
Researcher at Northwestern University
Publications - 217
Citations - 24119
Thomas V. O'Halloran is an academic researcher from Northwestern University. The author has contributed to research in topics: Zinc & Superoxide dismutase. The author has an hindex of 76, co-authored 207 publications receiving 22523 citations. Previous affiliations of Thomas V. O'Halloran include University of Birmingham & Michigan State University.
Papers
More filters
Journal ArticleDOI
Robust Structure and Reactivity of Aqueous Arsenous Acid–Platinum(II) Anticancer Complexes
Ðenana Miodragović,Jeremy A. Quentzel,Josh W. Kurutz,Charlotte L. Stern,Richard W. Ahn,Irawati Kandela,Andrew P. Mazar,Thomas V. O'Halloran +7 more
TL;DR: The first molecular adducts of platinum and arsenic based anticancer drugs - arsenoplatins - show unanticipated structure, substitution chemistry, and cellular cytotoxicity.
Journal ArticleDOI
Multiple heavy-atom reagents for macromolecular X-ray structure determination. Application to the nucleosome core particle.
TL;DR: These multiple heavy-atom compounds appear to be generally applicable to X-ray structure determination, and are particularly useful in conjunction with crystals having asymmetric units of large volume but lacking non-crystallographic symmetry elements.
Journal ArticleDOI
The 199Hg Chemical Shift as a Probe of Coordination Environments in Blue Copper Proteins
Lisa M. Utschig,Jeffery G. Wright,Gregg R. Dieckmann,Vincent L. Pecoraro,Thomas V. O'Halloran +4 more
Journal ArticleDOI
Macrogenomic engineering via modulation of the scaling of chromatin packing density.
Luay M. Almassalha,Greta M. Bauer,Wenli Wu,Lusik Cherkezyan,Di Zhang,Alexis Kendra,Scott Gladstein,John E. Chandler,David VanDerway,Brandon Luke L. Seagle,Andrey Ugolkov,Daniel D. Billadeau,Thomas V. O'Halloran,Andrew P. Mazar,Hemant K. Roy,Igal Szleifer,Shohreh Shahabi,Vadim Backman +17 more
TL;DR: It is shown that the rational modulation of chromatin density fluctuations can lead to a decrease in global transcriptional activity and intercellular transcriptional heterogeneity in cancer cells during chemotherapeutic responses to achieve near-complete cancer cell killing in vitro.